The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective

Journal of Crohn's and Colitis

Volumn 4, Issue 4, 2010, Pages 427-430

  Bager, Palle ^a   Dahlerup, Jens F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anemia; Economic evaluation; Inflammatory bowel disease; Iron treatment

Indexed keywords

FERINJECT; FERRIC HYDROXIDE SUCROSE; IRON CARBOXYMALTOSE; IRON DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; BUDGET; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INFUSION; ENTERITIS; FEMALE; HEALTH CARE COST; HUMAN; INCOME; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANEMIA, IRON-DEFICIENCY; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; FERRIC COMPOUNDS; HEALTH CARE COSTS; HUMANS; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; MALE; MALTOSE; MIDDLE AGED; YOUNG ADULT;

EID: 77957323453     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.01.007     Document Type: Article

References (17)

1. Gasche C. Anamia in IBD: the overlooked villain. Inflamm Bowel Dis 2000, 6:142-150.
2. Gasche C., Lomer M.C.E., Cavill I., Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004, 53:1190-1197.
3. Rockey D.C. Treatment of iron deficiency. Gastroenterology 2006, 130:1367-1368.
4. Gasche C., Berstad A., Befrits R., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:1545-1553.
5. Erichsen K. Iron therapy in inflammatory bowel disease. Thesis. Bergen: University of Bergen; 2005.
6. Vijverman A., Piront P., Belaiche J., Louis E. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 2006, 69:1-4.
7. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24:1507-1523.
8. Wilson A., Reyes E., Ofman J. Prevalence and outcomes of anamia in inflammatory bowel disease: a systematic review of literature. Am J Med 2004, 116:44-49.
9. Gisbert J.P., Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008, 103:1299-1307.
10. Pizzi L.T., Weston C.M., Goldfarb N.I., et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:47-52.
11. Wells C.W., Lewis S., Barton J.R., Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006, 12:123-130.
12. Lindgren S., Wikman O., Befits R., et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 44:838-845.
13. Kulnigg S., Stoinov S., Simanenkov V., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (Ferinject®) randomized controlled trial. Am J Gastroenterol 2007, 102:1-11.
14. WHO/UNICEF/UNU Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO/UNICEF/UNU consultation 1998, World Health Organization, Geneva.
15. Drummond M.F., O'Brian B., Stoddart G.L., et al. Methods for economic evaluation of health care programmes 2003, Oxford Medical Publications, Oxford. 2nd Ed.
16. Boonen A., Dagnelie P.C., Hesselink M.A., et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis 2002, 8:382-389.
17. Ershler W.B., Chen K., Reyes E.B., Dubois R. Economic burden of patients with anemia in selected diseases. Value Health 2005, 8:629-638.